For example, reduced EMX2 expression has been associated with poor prognosis in glioblastoma [12], lung adenocarcinoma, [13], and endometrial cancer [14], though mutations have not contributed to the risk of endometriosis [15]. This evidence concerns the gene EMX2 and glioblastoma.